Support, Educate, Empower Coaching Program Tied to Improved Glaucoma Meds Adherence

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 9, 2026.

via HealthDay

MONDAY, March 9, 2026 -- A Support, Educate, Empower (SEE) glaucoma coaching program improves medication adherence compared with standard written education, according to a study published online Feb. 26 in JAMA Ophthalmology.

Paula Anne Newman-Casey, M.D., from the University of Michigan in Ann Arbor, and colleagues compared the SEE intervention to standard written education on glaucoma medication adherence in a randomized clinical trial testing intervention superiority. A total of 236 participants were enrolled from the University of Michigan and Henry Ford Health System and randomly assigned to the SEE intervention or control group (117 and 118, respectively).

The researchers found that mean self-reported adherence was 63.9 percent. Medication adherence was significantly better in the SEE intervention group than the control group (mean, 77.6 versus 58.0 percent), and more participants in the SEE group achieved 80 percent or greater adherence (54.9 versus 23.7 percent). After adjustment for baseline distress, the difference in change in glaucoma-related distress was −0.3 between the intervention and control groups.

"The SEE personalized glaucoma coaching program demonstrated clinically significant improvements in glaucoma medication adherence and reductions in glaucoma-related distress compared with the control group receiving standard written education," the authors write.

One author had a patent pending for an eye drop adherence monitoring system and method.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-10 01:46

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords